what is a glp 1 gip The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 | Summary
Description
Besheer and Hodge 2005
It is currently in Phase 1/2 development for obesity and T2D
A BMI of 30 in a white individual carries equivalent diabetes risk to a BMI of approximately 23.9 in a South Asian individual and 26.9 in a Chinese individual
Evidence from clinical trials and real-world data suggests these medications can be used safely in many older people, but certain precautions are essential
This pharmacological assistance doesnt replace lifestyle changes but rather makes them more effective
Long-Term Follow-up: Even after reaching your goal, Dr
